Cesca Therapeutics is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine. The Company operates two divisions, ThermoGenesis and Cesca Clinical. Learn More
Copyright Nasdaq. Minimum 15 minutes delayed.
April 24, 2018 Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series™ Products That Provide Automated, Closed System Cellular Processing
April 17, 2018 Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series™ Products That Provide Automated, Closed System Cellular ProcessingMore News